In immune-competent mice, NACC1 or FKBP10 depletion attenuated tumor growth, 26.7% (sh336) to 37.6% (sh334) and 42.9% (sh876) to 46.8% (sh486), respectively (Fig. 5, G and J). Here, NACC1 is linked to neoplasm.